Julien Villeneuve

Julien Villeneuve

Auto-generated profile, based on publicly available information

Julien Villeneuve

IGF, University of Montpellier, CNRS, INSERM, Montpellier, France

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2017 in Annals of Intensive Care
Verified
Journal Article
Open access
PDF file
ADAntoine Dewitte
Antoine Dewitte
SLSébastien Lepreux
Sébastien Lepreux
JVJulien Villeneuve
Julien Villeneuve
CRClaire Rigothier
Claire Rigothier
CCChristian Combe
Christian Combe
JRJean Ripoche
Jean Ripoche
Beyond haemostasis, platelets have emerged as versatile effectors of the immune response. The contribution of platelets in inflammation, tissue integrity and defence against infections has considerably widened the spectrum of their role in health and disease. Here, we propose a narrative review that first describes these new platelet attributes. We then examine their relevance to microcirculatory alterations in multi-organ dysfunction, a major sepsis complication. Rapid progresses that are made on the knowledge of novel platelet functions should improve the understanding of thrombocytopenia, a common condition and a predictor of adverse outcome in sepsis, and may provide potential avenues for management and therapy.

19 May 2014 in eLife
Verified
Journal Article
Open access
CNCristina Nogueira
Cristina Nogueira
PEPatrik Erlmann
Patrik Erlmann
JVJulien Villeneuve
Julien Villeneuve
ASAntónio Jm Santos
António Jm Santos
EMEmma Martínez-Alonso
Emma Martínez-Alonso
VMVivek Malhotra
Vivek Malhotra
TANGO1 binds and exports Procollagen VII from the endoplasmic reticulum (ER). In this study, we report a connection between the cytoplasmic domain of TANGO1 and SLY1, a protein that is required for membrane fusion. Knockdown of SLY1 by siRNA arrested Procollagen VII in the ER without affecting the recruitment of COPII components, general protein secretion, and retrograde transport of the KDEL-containing protein BIP, and ERGIC53. SLY1 is known to interact with the ER-specific SNARE proteins Syntaxin 17 and 18, however only Syntaxin 18 was required for Procollagen VII export. Neither SLY1 nor Syntaxin 18 was required for the export of the equally bulky Procollagen I from the ER. Altogether, these findings reveal the sorting of bulky collagen family members by TANGO1 at the ER and highlight the existence of different export pathways for secretory cargoes one of which is mediated by the specific SNARE complex containing SLY1 and Syntaxin 18.

21 May 2013 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
DCDavid Cruz‐Garcia
David Cruz‐Garcia
MOMaria Ortega‐Bellido
Maria Ortega‐Bellido
MSMargherita Scarpa
Margherita Scarpa
JVJulien Villeneuve
Julien Villeneuve
MJMarko Jovic
Marko Jovic
VMVivek Malhotra
Vivek Malhotra
The BAR (Bin/Amphiphysin/Rvs) domain proteins arfaptin1 and arfaptin2 are localized to the trans‐Golgi network (TGN) and, by virtue of their ability to sense and/or generate membrane curvature, could play an important role in the biogenesis of transport carriers. We report that arfaptins contain an amphipathic helix (AH) preceding the BAR domain, which is essential for their binding to phosphatidylinositol 4‐phosphate (PI(4)P)‐containing liposomes and the TGN of mammalian cells. The binding of arfaptin1, but not arfaptin2, to PI(4)P is regulated by protein kinase D (PKD) mediated phosphorylation at Ser100 within the AH. We also found that only arfaptin1 is required for the PKD‐dependent trafficking of chromogranin A by the regulated secretory pathway. Altogether, these findings reveal the importance of PI(4)P and PKD in the recruitment of arfaptins at the TGN and their requirement in the events leading to the biogenesis of secretory storage granules.

6 December 2017 in Journal of Cell Biology
Verified
Journal Article
Open access
JVJulien Villeneuve
Julien Villeneuve
LBLaia Bassaganyas
Laia Bassaganyas
SLSebastien Lepreux
Sebastien Lepreux
MCMarioara Chiritoiu-Butnaru
Marioara Chiritoiu-Butnaru
PCPierre Costet
Pierre Costet
RSRandy Schekman
Randy Schekman
An appreciation of the functional properties of the cytoplasmic fatty acid binding protein 4 (FABP4) has advanced with the recent demonstration that an extracellular form secreted by adipocytes regulates a wide range of physiological functions. Little, however, is known about the mechanisms that mediate the unconventional secretion of FABP4. Here, we demonstrate that FABP4 secretion is mediated by a membrane-bounded compartment, independent of the conventional endoplasmic reticulum–Golgi secretory pathway. We show that FABP4 secretion is also independent of GRASP proteins, autophagy, and multivesicular bodies but involves enclosure within endosomes and secretory lysosomes. We highlight the physiological significance of this pathway with the demonstration that an increase in plasma levels of FABP4 is inhibited by chloroquine treatment of mice. These findings chart the pathway of FABP4 secretion and provide a potential therapeutic means to control metabolic disorders associated with its dysregulated secretion.

15 July 2013 in Journal of Cell Biology
Verified
Journal Article
Open access
YWYuichi Wakana
Yuichi Wakana
JVJulien Villeneuve
Julien Villeneuve
JGJosse van Galen
Josse van Galen
DCDavid Cruz-Garcia
David Cruz-Garcia
MTMitsuo Tagaya
Mitsuo Tagaya
VMVivek Malhotra
Vivek Malhotra
Here we report that the kinesin-5 motor Klp61F, which is known for its role in bipolar spindle formation in mitosis, is required for protein transport from the Golgi complex to the cell surface in Drosophila S2 cells. Disrupting the function of its mammalian orthologue, Eg5, in HeLa cells inhibited secretion of a protein called pancreatic adenocarcinoma up-regulated factor (PAUF) but, surprisingly, not the trafficking of vesicular stomatitis virus G protein (VSV-G) to the cell surface. We have previously reported that PAUF is transported from the trans-Golgi network (TGN) to the cell surface in specific carriers called CARTS that exclude VSV-G. Inhibition of Eg5 function did not affect the biogenesis of CARTS; however, their migration was delayed and they accumulated near the Golgi complex. Altogether, our findings reveal a surprising new role of Eg5 in nonmitotic cells in the facilitation of the transport of specific carriers, CARTS, from the TGN to the cell surface.

1 July 2009 in Experimental Hematology
Verified
Journal Article
Closed access
JVJulien Villeneuve
Julien Villeneuve
ABAnna Block
Anna Block
MBMarie-Caroline Le Bousse-Kerdilès
Marie-Caroline Le Bousse-Kerdilès
SLSébastien Lepreux
Sébastien Lepreux
PNPaquita Nurden
Paquita Nurden
ANAlan T. Nurden
Alan T. Nurden